2020
DOI: 10.2807/1560-7917.es.2020.25.47.2001752
|View full text |Cite
|
Sign up to set email alerts
|

Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020

Abstract: Three months after a coronavirus disease (COVID-19) outbreak in Kupferzell, Germany, a population-based study (n = 2,203) found no RT-PCR-positives. IgG-ELISA seropositivity with positive virus neutralisation tests was 7.7% (95% confidence interval (CI): 6.5–9.1) and 4.3% with negative neutralisation tests. We estimate 12.0% (95% CI: 10.4–14.0%) infected adults (24.5% asymptomatic), six times more than notified. Full hotspot containment confirms the effectiveness of prompt protection measures. However, 88% naï… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
62
4
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 70 publications
(73 citation statements)
references
References 24 publications
6
62
4
1
Order By: Relevance
“…At present, the United States Centers for Disease Control and Prevention (CDC) recommends diagnosis of acute SARS-CoV-2 infection via measurement of viral nucleic acid and antigen tests ( https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html ). Real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) is a reliable and relatively fast method for the identification of pathogenic nucleic acids in patient samples 6 . However, it has several disadvantages.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…At present, the United States Centers for Disease Control and Prevention (CDC) recommends diagnosis of acute SARS-CoV-2 infection via measurement of viral nucleic acid and antigen tests ( https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html ). Real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) is a reliable and relatively fast method for the identification of pathogenic nucleic acids in patient samples 6 . However, it has several disadvantages.…”
Section: Introductionmentioning
confidence: 99%
“…Another disadvantage is the requirement for relatively high concentrations of genetic material in a sample. Although real-time RT-PCR is considered to be a sensitive method for the detection of nucleic acid, the limit of detection for SARS-CoV-2 RNA is reported to be between 200 and 77,440 copies/mL, depending on the RNA extraction method and real-time RT-PCR assay being used 6 , 9 , 10 .…”
Section: Introductionmentioning
confidence: 99%
“…Das E (Hüllprotein)-Gen ist ein stark konserviertes Gen, das in SARS und in SARS-CoV‑2 identisch ist (pan-Sarbecovirus-Gen). Daher wird in einem Protokoll empfohlen, die E (Hüllprotein)-Genamplifikation als Vortest für den Nachweis von SARS-Viren zu verwenden und im Falle eines positiven Ergebnisses anschließend 1 oder 2 weitere Gene von SARS-CoV‑2 als Bestätigungstest zu amplifizieren ( N -[Nukleokapsidprotein]-Gen, RdRp [RNA-abhängiges RNA-Polymerase]-Gen) [ 10 ]. Das S (Spikeprotein)-Gen weist aufgrund von hohem Selektionsdruck häufiger Mutationen auf, weshalb die alleinige Amplifikation des S -Gens nicht empfohlen wird.…”
Section: Sars-cov-2-nachweismethodsenunclassified
“…Molecular techniques have been designed to address this need 9 . According to the World Health Organization (WHO), the gold standard method to detect SARS-CoV-2 is real-time polymerase chain reaction (RT-PCR) using TaqMan probes, which precisely detect the presence of the virus 10 . However, due to the intensive labor required to perform the technique, the reagents involved, and the limited availability of kits, many diagnoses are based only on late-stage symptoms 11 .…”
Section: Introductionmentioning
confidence: 99%